Chemed Corporation

Equities

CHE

US16359R1032

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-05-24 pm EDT 5-day change 1st Jan Change
555.4 USD +0.01% Intraday chart for Chemed Corporation -1.79% -5.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Declaration of Voting Results by Chemed Corporation CI
RBC Cuts Price Target on Chemed to $697 From $712, Maintains Outperform Rating MT
Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable June 18 to Shareholders of Record on May 30 MT
Chemed Insider Sold Shares Worth $2,270,160, According to a Recent SEC Filing MT
Transcript : Chemed Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says MT
Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024
Chemed Q1 Adjusted Earnings, Revenue Rise -- Shares Down After Hours MT
Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 Revenue $589.2M, vs. Street Est of $591.1M MT
Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 EPS $5.20, vs. Street Est of $5.48 MT
Tranche Update on Chemed Corporation's Equity Buyback Plan announced on February 22, 2011. CI
Chemed Corporation Reiterates Earnings Guidance for Full Year 2024 CI
Chemed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chemed Corporation Receives Shareholders Proposal from John Chevedden CI
Chemed Insider Sold Shares Worth $1,283,300, According to a Recent SEC Filing MT
Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing MT
Transcript : Chemed Corporation Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 12:00 PM
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating MT
Transcript : Chemed Corporation, Q4 2023 Earnings Call, Feb 28, 2024
Chemed Q4 Adjusted Earnings, Revenue Rise; Sets 2024 Outlook MT
Tranche Update on Chemed Corporation's Equity Buyback Plan announced on February 22, 2011. CI
Earnings Flash (CHE) CHEMED CORPORATION Reports Q4 EPS $6.60 MT
Earnings Flash (CHE) CHEMED CORPORATION Posts Q4 Revenue $350M MT
Chart Chemed Corporation
More charts
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
555.4 USD
Average target price
685 USD
Spread / Average Target
+23.34%
Consensus